Arch's golden returns

Tallying Arch Venture's wins from Agios and Receptos

Mid-month SEC filings show Arch Venture Partners has used two companies with roaring stock prices - Agios Pharmaceuticals Inc. (NASDAQ:AGIO) and Receptos Inc. (NASDAQ:RCPT) - to completely pay back LPs in its $400 million seventh fund. A potentially

Read the full 389 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE